# OnCo record paper-preopanc-neoadjuvant-chemoradiotherapy-long-term-jco-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-preopanc-neoadjuvant-chemoradiotherapy-long-term-jco-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-preopanc-neoadjuvant-chemoradiotherapy-long-term-jco-2022" ;
  schema:name "PREOPANC long-term results: neoadjuvant gemcitabine-based chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer"@en ;
  schema:description "Giving chemotherapy and radiotherapy before the operation, rather than operating first, tripled the share of patients alive at five years in this Dutch trial, with the gain clearest in borderline resectable tumours. It is the strongest randomised case for treating borderline resectable pancreatic cancer before surgery."@en ;
  schema:url <https://onco.cc/key-papers/paper-preopanc-neoadjuvant-chemoradiotherapy-long-term-jco-2022/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.21.02233>, <https://pubmed.ncbi.nlm.nih.gov/35084987/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.21.02233> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Versteijne E, van Dam JL, Suker M, et al." ;
  onco:cancers <https://onco.cc/cancers/borderline-resectable-pdac/>, <https://onco.cc/cancers/resectable-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/> ;
  onco:trials <https://onco.cc/trials/preopanc/> ;
  onco:journals <https://onco.cc/journals/jco/> .